Lv1
50 积分 2025-07-15 加入
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial
1个月前
已完结
Systematic Review of Hypofractionated Radiation Therapy for the Treatment of Oesophageal Squamous Cell Carcinoma and Oesophageal Adenocarcinoma
1个月前
已关闭
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
1个月前
已完结
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair–Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
2个月前
已完结
Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial
3个月前
已完结
Novel Therapies for Pancreatic Cancer
3个月前
已完结
Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation
3个月前
已完结
CDC20 promotes radioresistance of prostate cancer by activating Twist1 expression
3个月前
已完结
胸段食管鳞癌术前同步放化疗不同放疗分割方式的临床研究
11个月前
已完结
皖公网安备34019202002308
